Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 2Vomiting 1Nausea 1Fallopian Tube Neoplasms 1Brenner Tumor 1

Interventions

Dexamethasone 7Aprepitant 6Ondansetron 4Granisetron 3Calcium Dobesilate 3fosaprepitant 2dexamethasone acetate 2dexamethasone 21-phosphate 2Surveys and Questionnaires 2ramosetron 1netupitant, palosentron drug combination 1auricularum 1Tropisetron 1Sugars 1Saline Solution 1Psychiatric Rehabilitation 1Platinum 1Octreotide 1Massage 1Interviews as Topic 1Immunoenzyme Techniques 1Electroacupuncture 1Cyproheptadine 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1Analgesia 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × auricularum × Gynecologic × Clear all
NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡